These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21166944)

  • 1. Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast?
    Kawasaki T; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Murata S; Inoue S; Tsunoda H; Katoh R
    Pathol Int; 2011 Jan; 61(1):49-51. PubMed ID: 21166944
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of CD56 and CD57 immunostainings for discrimination between endocrine ductal carcinoma in situ and intraductal papilloma.
    Tajima S; Maeda I; Kanemaki Y; Nakajima Y; Tatsunami S; Fukuda M; Takagi M
    Pathol Int; 2010 Jun; 60(6):459-65. PubMed ID: 20518901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
    Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
    Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.
    Ding Y; Ruan Q
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):405-7. PubMed ID: 17120733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.
    Tse GM; Tan PH; Ma TK; Gilks CB; Poon CS; Law BK
    J Clin Pathol; 2005 Nov; 58(11):1185-8. PubMed ID: 16254109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
    Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
    Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
    Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
    Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal approach to the detection of intraductal lesions of the breast.
    Matsunaga T; Misaka T; Hosokawa K; Taira S; Kim K; Serizawa H; Akiyama H; Fujii M
    Breast Cancer Res Treat; 2009 Nov; 118(1):9-13. PubMed ID: 18846422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microinvasive neuroendocrine carcinoma arising from a central papilloma of the breast.
    Kawasaki T; Suda M; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Ito Y; Tsunoda H; Katoh R
    J Clin Pathol; 2011 Jun; 64(6):549-51. PubMed ID: 21310798
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ.
    Furuya C; Kawano H; Yamanouchi T; Oga A; Ueda J; Takahashi M
    Pathol Int; 2012 Jun; 62(6):381-90. PubMed ID: 22612506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary metastasis of an unknown neuroendocrine breast carcinoma mimicking a pituitary adenoma.
    Senetta R; Castellano I; Garbossa D; Sapino A; Cassoni P
    Pathology; 2013 Jun; 45(4):422-4. PubMed ID: 23635818
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytologic characteristics of endocrine ductal carcinoma in situ of the breast. A case report.
    Yin H; Schinella R
    Acta Cytol; 2002; 46(5):873-6. PubMed ID: 12365222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse neuroendocrine differentiation in a morphologically composite mammary infiltrating ductal carcinoma: a case report and review of the literature.
    David O; Bhattacharjee M
    Arch Pathol Lab Med; 2003 Mar; 127(3):e131-4. PubMed ID: 12653600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Galactoscopy--is it a new interventional method for breast diagnosis?].
    Schulz-Wendtland R; Aichinger U; Krämer S; Schaaf H; Tartsch M; Bautz W
    Rofo; 2002 Aug; 174(8):1015-7. PubMed ID: 12142980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases.
    Kawasaki T; Nakamura S; Sakamoto G; Kondo T; Tsunoda-Shimizu H; Ishii Y; Nakazawa T; Mochizuki K; Yamane T; Inoue M; Inoue S; Katoh R
    Cytopathology; 2011 Feb; 22(1):43-9. PubMed ID: 20236292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Papillary lesions of the breast].
    Ni YB; Tse GM
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):721-6. PubMed ID: 24447546
    [No Abstract]   [Full Text] [Related]  

  • 18. ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer.
    Inaji H; Koyama H; Motomura K; Noguchi S; Mori Y; Kimura Y; Sugano K; Ohkura H
    Tumour Biol; 1993; 14(5):271-8. PubMed ID: 7901888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44s as a surrogate marker for distinguishing intraductal papilloma from papillary carcinoma of the breast.
    Saddik M; Lai R
    J Clin Pathol; 1999 Nov; 52(11):862-4. PubMed ID: 10690183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary neuroendocrine tumor of the breast: imaging features.
    Chang ED; Kim MK; Kim JS; Whang IY
    Korean J Radiol; 2013; 14(3):395-9. PubMed ID: 23690703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.